[1] |
TSENG C E,BUYON J P,KIM M,et al.The effect of moderate-dose corticosteroids in preventing severe flares in patients with serologically active,but clinically stable,systemic lupus erythematosus: findings of a prospective,randomized,double-blind,placebo-controlled trial[J]. Arthritis Rheum,2006,54(11):3623-3632.
|
[2] |
CAMBRIDGE G,LEANDRO M J,TEODORESCU M,et al.B cell depletion therapy in systemic lupus erythematosus:effect on autoantibody and antimicrobial antibody profiles[J]. Arthritis Rheum,2006,54(11):3612-3622.
|
[3] |
MANSON J J,MAURI C,EHRENSTEIN M R.Natural serum IgM maintains immunological homeostasis and prevents autoimmunity[J]. Springer Semin Immunopathol,2005,26(4):425-432.
|
[4] |
WITTE T.IgM antibodies against dsDNA in SLE[J]. Clin Rev Allergy Immunol,2008,34(3):345-347.
|
[5] |
KEISERMAN B,RONCHETTI M R,MONTICIELO O A,et al.Concomitance of IgM and IgG anti-ds-DNA antibodies does not appear to associate to active lupus nephritis[J]. Open Rheumatol J,2013,7:101-104.
|
[6] |
VILLALTA D,BIZZARO N,BASSI N,et al.Anti-dsDNA antibody isotypes in systemic lupus erythematosus: IgA in addition to IgG anti-dsDNA help to identify glomerulonephritis and active disease[J]. PLoS One,2013,8(8):e71458.
|
[7] |
SHOENFELD Y,TOUBI E.Protective autoantibodies:role in homeostasis,clinical importance,and therapeutic potential[J]. Arthritis Rheum,2005,52(9):2599-2606.
|
[8] |
DORIA A,GATTO M.Nephritogenic-antinephritogenic antibody network in lupus glomerulonephritis[J]. Lupus,2012,21(4):1492-1496.
|
[9] |
PISETSKY D S.Antinuclear antibodies in rheumatic disease: a proposal for a function-based classification[J]. Scand J Immunol,2012,76(3):223-228.
|
[10] |
FRESE S,DIAMOND B.Structural modification of DNA-a therapeutic option in SLE?[J]. Nat Rev Rheumatol,2011,7(12):733-738.
|
[11] |
AMOURA Z,KOUTOUZOV S,CHABRE H,et al.Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus[J]. Arthritis Rheum,2000,43(1):76-84.
|
[12] |
MASON L J,LAMBRIANIDES A,HALEY J D,et al.Stable expression of a recombinant human antinucleosome antibody to investigate relationships between antibody sequence,binding properties,and pathogenicity[J]. Arthritis Res Ther,2005,7(5):R971-R983.
|
[13] |
WERWITZKE S,TRICK D,KAMINO K,et al.Inhibition of lupus disease by anti-double-stranded DNA antibodies of the IgM isotype in the(NZB× NZW)F1 mouse[J]. Arthritis Rheum,2005,52(11):3629-3638.
|
[14] |
XIA Y,ERYILMAZ E,ZHANG Q,et al.Anti-DNA antibody mediated catalysis is isotype dependent[J]. Mol Immunol,2016,69:33-43.
|
[15] |
BONANNI A,VAGLIO A,BRUSCHI M,et al.Multi-antibody composition in lupus nephritis: isotype and antigen specificity make the difference[J]. Autoimmun Rev,2015,14(8):692-702.
|
[16] |
SILVA-SANCHEZ A,LIU C R,VALE A M, et al.Violation of an evolutionarily conserved immunoglobulin diversity gene sequence preference promotes production of dsDNA-specific IgG antibodies[J]. PLoS One,2015,10(2):e0118171.
|